• Keine Ergebnisse gefunden

Letter to the editor : Homeopathic treatment of children with attention deficit disorder: a randomized, double blind, placebo-controlled crossover trial. H. Frei R. Everts, K.v. Ammon et al. Eur J Pediatr. 2005; 164: 758-767

N/A
N/A
Protected

Academic year: 2022

Aktie "Letter to the editor : Homeopathic treatment of children with attention deficit disorder: a randomized, double blind, placebo-controlled crossover trial. H. Frei R. Everts, K.v. Ammon et al. Eur J Pediatr. 2005; 164: 758-767"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

source: https://doi.org/10.7892/boris.20223 | downloaded: 31.1.2022

CORRESPONDENCE

Letter to the editor

Homeopathic treatment of children with attention deficit disorder: a randomized, double blind, placebo-controlled crossover trial. H. Frei R. Everts, K.v. Ammon et al. Eur J Pediatr. 2005; 164: 758–767

Rolf H. Adler&Norbert Herschkowitz&

Christoph E. Minder

Received: 20 April 2006 / Accepted: 6 July 2006 / Published online: 19 September 2006

#Springer-Verlag 2006

The authors deserve recognition for their effort to do a well- designed trial in the contested field of homoeopathy.

However, for the following reasons we doubt that the effectivity of homeopathic treatment is supported by this study:

1. The exclusion of a quarter of all eligible study probands after they failed to show any improvement in the initial open trial phase does not correspond to usual practice and limits the generalisability of the results of the trial.

2. The worsening of symptoms in the double-blind trial phase under verum in arm A contradicts the hypothesis of

the effectivity of homeopathic treatment. This lack of effect cannot be ascribed to the expectations of parents, as the authors argue.

3. The slight improvement of symptoms under verum in arm B in the second phase is with 1.67 negligible compared to the improvement of nearly 10 points seen in the open pre-trial phase (CGI scale). In our opinion, this points to the ineffectiveness of the treatment. This is all the more true as the p-value is only around .05, from the testing of a rather large number of scales. The sizeable improvement in the open after-trial phase points to a large effect of the doctors' encouragement.

In our view, the overall picture emerging from this study is most simply interpreted assuming no intrinsic homeop- athy effect, but rather a pronounced effect of the medical treatment procedure on the family system.

Eur J Pediatr (2007) 166:509 DOI 10.1007/s00431-006-0262-5

R. H. Adler (*)

:

N. Herschkowitz

:

C. E. Minder Medical School, University of Bern,

Bern, Switzerland e-mail: rolf.adler@tele2.ch

Referenzen

ÄHNLICHE DOKUMENTE

In a second phase II trial including 36 patients with breast cancer treated with Radium-223 in associ- ation with hormonal therapy, disease control in 49% of patients and a

In conclusion, for infants aged 1–3 months old undergoing bladder catheterization in the ED, administration of an oral sweet solution 2 min before the procedure did not

A comparison with the average dimensions of the maxillary canine reported by De Jonge (1958) shows that only the root was exceptionally long (26 mm vs an average value of 16.1 mm),

Your results show that “RDA values measured in the 1998 study were lower for all seven dentifrices that were also tested in the present study”.. In your discussion you only focus

This pilot shows a tendency to lower viral loads in the ivermectin group, a tendency to lower IgG titers that may re fl ect milder disease and clinical bene fi t in cardinal symptoms

Also, at the end of the following 6 weeks of open label treatment, the ADHD symptoms of both treatment groups had re- turned to around their values at beginning of the crossover

In fact, ocular symptoms may occur in COVID-19 since entry of the severe acute respiratory syn- drome coronavirus 2 (SARS-CoV2) into human cells occurs after viral protein binds to

IRs were defined as the number of patients with events during the risk period divided by the sum of the durations of exposures of the patients during the risk period (time to